The Ten Biggest Investment Rounds in Israeli Tech in 2018
As the year comes to a close, CTech takes a look at the biggest funding rounds of the past 12 months
1. JFrog Ltd.
Amount: $165 million, announced in October
Investors in the round: Insight Venture Partners led the round, with participation from Geodesic Capital and Spark Capital, and existing investors including Dell Technologies subsidiary VMware Inc., Battery Ventures LP, Scale Venture Partners, Gemini Israel Ventures, and Qumra Capital Management Ltd.
Founders: Shlomi Ben Haim, Yoav Landman, and Frederic Simon
Year founded: 2008
Total funding to date: around $230 million
JFrog develops tools designed to streamline the coding process and automate software updates, with customers including Amazon, Google, Bank of America, Uber, and Netflix. The company employs around 450 people in its offices in Sunnyvale, California, Israeli coastal town Netanya, Beijing, Toulouse, and Bengaluru, India.
Amount: $125 million, announced in June
Investors: Boyu Capital Consultancy Co. Ltd. led the round, with participation from DC Thomson
Sector: Retail Analytics
Founders: Joel Bar-El and Dror Feldheim
Year founded: 2010
Total funding to date: $235 million
Headquartered in Singapore with a research and development center in Tel Aviv, Trax enables retailers to keep track of their stock using image recognition and computer vision analytic tools. The company operates in over 50 countries, with clients including some of Coca Cola's anchor bottlers and Henkel AG & Company.
3. eToro Group Ltd.
Amount: $100 million, announced in March
Investors: China Minsheng Financial Holding Corporation Ltd. led the round, with participation from SBI Group and Korea Investment Partners.
Sector: alternative financing
Founders: David Ring, Ronen Assia, Yoni Assia
Year founded: 2007
Total funding to date: $162 million
eToro operates a website that enables users to make investments in a variety of financial assets. Investments can be made manually, or “socially” by copying the trading activity of other users.
Amount: $80 million, announced in June
Investors in the round: Volkswagen, Access Industries, Baring Vistok, MCI
Founders: Shahar Waiser and Roi More
Year founded: 2010
Total funding to date: around $700 million
Israel-based Gett develops a taxi-hailing app that connects users with registered taxis and cabs. The company operates in over 120 cities across the U.S., U.K., Russia and Israel, and has over 13,000 corporate clients. in December, German weekly Der Spiegel reported that Volswagen cut down its investment in Gett to 16 million euros.
Amount: $80 million, announced in September
Investors in the round: Insight Venture Partners led the round.
Sector: business intelligence
Founders: Guy Boyangu, Eldad Farkash, Adi Azaria, Aviad Harell
Year founded: 2004
Total funding to date: around $200 million
Sisense develops software that allows companies with large datasets to gain insights on customers and users without requiring professional data analysis. Customers include Nasdaq, Rolls-Royce PLC, and General Electric. Based in Ramat Gan in the greater Tel Aviv area, the company has over 450 employees in Israel, Kiev, Tokyo, New York, and Scottsdale, Arizona.
Amount: the company raised $60 million in equity in June and $200 million in debt financing in May. In July the company announced it has added another $12 million to the round, bringing the total to $72 million.
Investors in the round: Menlo Ventures led the June round, with participation from SVB Capital and existing investors. Credit Suisse granted BlueVine the credit line in May.
Sector: Alternative financing
Founders: Eyal Lifshitz, Moti Shatner, Nir Klar
Year founded: 2013
Total funding to date: $140 million in equity, $500 million in credit lines
BlueVine offers small and medium-sized businesses capital financing, either by credit line or invoice factoring, which allows businesses to receive cash advances on outstanding invoices.
7. V-Wave Ltd.
Amount: $70 million, announced in April
Investors in the round: Deerfield Management Company L.P. led the round, with participation from Endeavour Vision SA, Quark Venture Inc., Aperture Venture Partners LLC, Johnson & Johnson Innovation, Edwards Lifesciences, BRM Group, and Pontifax Ltd.
Sector: medical shunts
Founders: Yaacov Nitzan and Gad Keren
Year founded: 2009
Total funding to date: $104.5 million
Israel-headquartered V-Wave develops a minimally invasive implanted shunt device for treating patients with severe heart failure. According to the company, its device can help control elevated left atrial pressure, the primary cause of breathing difficulty and hospitalization due to heart failure.
8. Valens Semiconductor Ltd.
Amount: $63 million, announced in November
Investors in the round: Oppenheimer Asset Management and Linse Capital
Sector: automotive, semiconductor
Founders: Dror Jerushalmi, Eyran Lida, and Massad Eyal
Year founded: 2006
Total funding to date: $167 million
Israel-based Valens manufactures semiconductor products for the delivery of uncompressed HD multimedia content for the automotive, industrial, and consumer electronics markets. The company employs 350 people in offices in Hod Hasharon, a town in central Israel, in Pasadena, and in Asia.
9. Claroty Ltd.
Amount: $60 million, announced in June
Investors in the round: Temasek Holdings led the round, with participation from Rockwell Automation, Aster Capital, Next47, Envision Ventures, Tekfen Ventures, Bessemer Venture Partners, Team8, Innovation Endeavors, ICV
Founders: Amir Zilberstein, Benny Porat, Galina Antova
Year founded: 2014
Total funding to date: $93 million
Claroty develops and markets cybersecurity platform for industrial networks. Headquartered in New York, the company also has an office in Tel Aviv.
10. 89Bio Ltd.
Amount: $60 million, announced in October
Investors in the round: OrbiMed Advisors LLC and its Israeli venture arm led the round, with participation from Longitude Capital Management Co. LLC., RA Capital Management LLC, and Pontifax Ltd.
Founders: OrbiMed Advisors
Year founded: 2018
Total funding to date: around $60 million
Incorporated in Israel in January, clinical-stage 89Bio develops treatments for liver and metabolic disorders. The company’s pipeline of biologic and small molecule drug candidates was acquired from Teva Pharmaceutical Industries Ltd., and several of the company's lead executives are former Teva employees.